Neuron Biopharma

Ownership

Public

Therapeutic Areas

Neurology

Stage

Preclinical

Modalities

Small molecule

Neuron Biopharma General Information

Company focused on developing compounds for neurodegenerative diseases, particularly Alzheimer's disease

Contact Information

Website

Primary Industry

[ "Biotech", "CRO", "Pharma" ]

Corporate Office

Granada,
Spain

Drug Pipeline

No pipeline data available

For full access to Neuron Biopharma's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Neuron Biopharma Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Neuron Biopharma's complete valuation and funding history, request access »